Exelixis Inc (NAS:EXEL)
$ 20.91 -0.32 (-1.51%) Market Cap: 6.09 Bil Enterprise Value: 5.42 Bil PE Ratio: 32.52 PB Ratio: 2.90 GF Score: 92/100

Exelixis Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 09, 2021 / 04:30PM GMT
Release Date Price: $22.2 (+0.45%)
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

Good morning, everybody. Welcome to Barclays Healthcare Conference. My name is Peter Lawson. I'm one of the biotech analysts at Barclays, and I just want to thank everyone for taking time out of their day. For questions, institutional clients can e-mail me at [email protected] or ping me on Bloomberg.

And it's my great pleasure today to introduce the management team from Exelixis, so Mike Morrison -- Morrissey. Thank you so much.

Questions & Answers

Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

And I guess, maybe to kind of kick things off, Mike, just an opening question would be your 2- to 3-minute kind of overview of like your kind of differentiation in the oncology space. There's lots of oncology companies. How you're differentiated? And kind of what do you define as your core competencies?

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

Yes, sounds good.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot